Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 94 | 2024 | 2634 | 11.130 |
Why?
|
Tachycardia, Ventricular | 52 | 2024 | 1261 | 7.190 |
Why?
|
Sarcoidosis | 23 | 2024 | 520 | 4.190 |
Why?
|
Defibrillators, Implantable | 39 | 2024 | 1483 | 3.880 |
Why?
|
Cardiomyopathies | 32 | 2024 | 1948 | 3.600 |
Why?
|
Arrhythmias, Cardiac | 26 | 2023 | 2234 | 3.210 |
Why?
|
Atrial Fibrillation | 50 | 2024 | 5031 | 3.080 |
Why?
|
Pulmonary Veins | 15 | 2024 | 716 | 2.670 |
Why?
|
Electrocardiography | 45 | 2024 | 6346 | 2.330 |
Why?
|
Heart Conduction System | 16 | 2023 | 992 | 2.160 |
Why?
|
Therapeutic Irrigation | 9 | 2023 | 289 | 2.070 |
Why?
|
Electrophysiologic Techniques, Cardiac | 25 | 2024 | 480 | 2.010 |
Why?
|
Electrodes | 5 | 2024 | 610 | 1.720 |
Why?
|
Myocardium | 15 | 2023 | 4725 | 1.660 |
Why?
|
Ventricular Fibrillation | 12 | 2022 | 534 | 1.550 |
Why?
|
Pericardium | 10 | 2024 | 664 | 1.540 |
Why?
|
Endocardium | 5 | 2023 | 246 | 1.420 |
Why?
|
Atrioventricular Block | 5 | 2019 | 132 | 1.350 |
Why?
|
Pacemaker, Artificial | 10 | 2024 | 805 | 1.340 |
Why?
|
Heart Injuries | 2 | 2023 | 203 | 1.210 |
Why?
|
Cattle | 16 | 2023 | 3841 | 1.190 |
Why?
|
Ventricular Premature Complexes | 6 | 2022 | 108 | 1.140 |
Why?
|
Heart Rate | 16 | 2024 | 4181 | 1.140 |
Why?
|
Electric Countershock | 15 | 2022 | 532 | 1.140 |
Why?
|
Heart Block | 5 | 2018 | 384 | 1.130 |
Why?
|
Coronary Sinus | 2 | 2020 | 84 | 1.110 |
Why?
|
Cardiac Resynchronization Therapy | 6 | 2024 | 557 | 1.060 |
Why?
|
Sarcoidosis, Pulmonary | 3 | 2017 | 45 | 1.050 |
Why?
|
Heart Ventricles | 14 | 2023 | 3796 | 1.040 |
Why?
|
Atrial Appendage | 3 | 2023 | 278 | 1.040 |
Why?
|
Tachycardia, Supraventricular | 6 | 2022 | 266 | 1.040 |
Why?
|
Cardiac Surgical Procedures | 5 | 2023 | 3621 | 0.940 |
Why?
|
Heart Septum | 4 | 2016 | 299 | 0.920 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 3 | 2021 | 139 | 0.910 |
Why?
|
Atrial Flutter | 6 | 2021 | 244 | 0.910 |
Why?
|
Propanolamines | 7 | 2021 | 163 | 0.900 |
Why?
|
Cardiac Pacing, Artificial | 8 | 2011 | 852 | 0.890 |
Why?
|
Bundle-Branch Block | 5 | 2024 | 276 | 0.880 |
Why?
|
Cicatrix | 5 | 2024 | 785 | 0.860 |
Why?
|
Action Potentials | 8 | 2024 | 1825 | 0.850 |
Why?
|
Accessory Atrioventricular Bundle | 3 | 2021 | 57 | 0.850 |
Why?
|
Heart Atria | 6 | 2023 | 1333 | 0.840 |
Why?
|
Anti-Arrhythmia Agents | 13 | 2022 | 763 | 0.820 |
Why?
|
Bundle of His | 4 | 2021 | 99 | 0.810 |
Why?
|
Equipment Failure | 6 | 2012 | 577 | 0.790 |
Why?
|
Body Surface Potential Mapping | 8 | 2019 | 223 | 0.780 |
Why?
|
Temperature | 5 | 2023 | 2224 | 0.770 |
Why?
|
Liposomes | 2 | 2023 | 784 | 0.750 |
Why?
|
Hot Temperature | 4 | 2023 | 1438 | 0.750 |
Why?
|
Ventricular Function, Left | 14 | 2023 | 3873 | 0.730 |
Why?
|
Electrodes, Implanted | 3 | 2023 | 838 | 0.730 |
Why?
|
Amiodarone | 3 | 2017 | 217 | 0.690 |
Why?
|
Tachycardia, Reciprocating | 2 | 2017 | 12 | 0.670 |
Why?
|
Tachycardia | 4 | 2022 | 597 | 0.640 |
Why?
|
Ventricular Dysfunction, Left | 8 | 2018 | 2118 | 0.640 |
Why?
|
Esophageal Fistula | 1 | 2019 | 59 | 0.630 |
Why?
|
Receptors, Adrenergic, beta-1 | 6 | 2021 | 52 | 0.620 |
Why?
|
Heart Failure | 17 | 2024 | 11670 | 0.600 |
Why?
|
Papillary Muscles | 4 | 2022 | 192 | 0.590 |
Why?
|
Heart | 6 | 2023 | 4403 | 0.590 |
Why?
|
Humans | 203 | 2024 | 760740 | 0.580 |
Why?
|
Catheters | 5 | 2023 | 423 | 0.580 |
Why?
|
Electric Impedance | 5 | 2024 | 751 | 0.580 |
Why?
|
Treatment Outcome | 65 | 2024 | 64572 | 0.570 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 3 | 2014 | 161 | 0.550 |
Why?
|
Equipment Failure Analysis | 3 | 2010 | 843 | 0.540 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2016 | 29 | 0.530 |
Why?
|
Electrocardiography, Ambulatory | 4 | 2019 | 574 | 0.520 |
Why?
|
Myocarditis | 4 | 2023 | 788 | 0.510 |
Why?
|
Prosthesis Implantation | 4 | 2024 | 591 | 0.510 |
Why?
|
Equipment Design | 10 | 2023 | 3501 | 0.510 |
Why?
|
Radiosurgery | 2 | 2024 | 1339 | 0.500 |
Why?
|
Heart Diseases | 6 | 2023 | 2778 | 0.500 |
Why?
|
Ablation Techniques | 2 | 2016 | 246 | 0.500 |
Why?
|
Middle Aged | 101 | 2024 | 220603 | 0.500 |
Why?
|
Ventricular Function, Right | 1 | 2019 | 617 | 0.490 |
Why?
|
Thermography | 1 | 2015 | 63 | 0.490 |
Why?
|
Device Removal | 3 | 2020 | 629 | 0.490 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2016 | 116 | 0.490 |
Why?
|
Pericardial Effusion | 1 | 2017 | 247 | 0.490 |
Why?
|
Materials Testing | 2 | 2016 | 863 | 0.490 |
Why?
|
Recurrence | 16 | 2024 | 8426 | 0.480 |
Why?
|
Ethanol | 3 | 2016 | 1320 | 0.470 |
Why?
|
Stroke Volume | 20 | 2024 | 5486 | 0.460 |
Why?
|
Ferric Compounds | 1 | 2016 | 378 | 0.460 |
Why?
|
Esophagus | 2 | 2023 | 1031 | 0.450 |
Why?
|
Male | 122 | 2024 | 360402 | 0.450 |
Why?
|
Nanotubes, Carbon | 1 | 2014 | 71 | 0.450 |
Why?
|
Energy Transfer | 1 | 2013 | 108 | 0.450 |
Why?
|
Pulmonary Fibrosis | 1 | 2017 | 505 | 0.440 |
Why?
|
Diagnostic Errors | 3 | 2011 | 1265 | 0.440 |
Why?
|
Sodium Chloride | 2 | 2015 | 586 | 0.440 |
Why?
|
Swine | 8 | 2023 | 5908 | 0.440 |
Why?
|
Echocardiography | 9 | 2024 | 4987 | 0.430 |
Why?
|
Aged | 82 | 2024 | 169092 | 0.430 |
Why?
|
Septal Occluder Device | 1 | 2014 | 125 | 0.420 |
Why?
|
Death, Sudden, Cardiac | 10 | 2022 | 1551 | 0.420 |
Why?
|
Hepatic Veins | 1 | 2013 | 112 | 0.410 |
Why?
|
Heart Transplantation | 5 | 2023 | 3233 | 0.410 |
Why?
|
Adrenergic beta-Antagonists | 7 | 2021 | 1241 | 0.410 |
Why?
|
Environment | 1 | 2018 | 1123 | 0.410 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2013 | 188 | 0.410 |
Why?
|
Female | 113 | 2024 | 392203 | 0.400 |
Why?
|
Postoperative Complications | 10 | 2020 | 15609 | 0.400 |
Why?
|
Cryosurgery | 3 | 2023 | 468 | 0.400 |
Why?
|
Atrioventricular Node | 3 | 2021 | 179 | 0.390 |
Why?
|
Metal Nanoparticles | 1 | 2016 | 399 | 0.390 |
Why?
|
Electrophysiological Phenomena | 1 | 2013 | 306 | 0.380 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2016 | 1310 | 0.380 |
Why?
|
Tetralogy of Fallot | 4 | 2018 | 618 | 0.370 |
Why?
|
Heart-Assist Devices | 5 | 2017 | 1288 | 0.370 |
Why?
|
Epicardial Mapping | 2 | 2021 | 51 | 0.350 |
Why?
|
Time Factors | 29 | 2024 | 39908 | 0.340 |
Why?
|
Myocardial Infarction | 9 | 2011 | 11458 | 0.310 |
Why?
|
Predictive Value of Tests | 15 | 2024 | 15250 | 0.310 |
Why?
|
Colorado | 5 | 2019 | 165 | 0.290 |
Why?
|
Venous Thrombosis | 1 | 2017 | 1303 | 0.290 |
Why?
|
Adult | 56 | 2022 | 220995 | 0.280 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2012 | 831 | 0.280 |
Why?
|
Risk Assessment | 19 | 2024 | 23974 | 0.270 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 1582 | 0.270 |
Why?
|
Risk Factors | 32 | 2024 | 74128 | 0.270 |
Why?
|
Prosthesis-Related Infections | 2 | 2023 | 487 | 0.270 |
Why?
|
Perciformes | 2 | 2018 | 24 | 0.270 |
Why?
|
Animals | 24 | 2024 | 168202 | 0.260 |
Why?
|
Retrospective Studies | 38 | 2024 | 80583 | 0.250 |
Why?
|
Pulmonary Valve | 3 | 2018 | 411 | 0.240 |
Why?
|
Cardiotonic Agents | 1 | 2007 | 539 | 0.240 |
Why?
|
Therapy, Computer-Assisted | 1 | 2006 | 266 | 0.230 |
Why?
|
Heart Arrest | 2 | 2011 | 1513 | 0.230 |
Why?
|
Philadelphia | 5 | 2019 | 267 | 0.230 |
Why?
|
Electric Stimulation Therapy | 1 | 2010 | 626 | 0.230 |
Why?
|
Atrial Premature Complexes | 2 | 2017 | 17 | 0.230 |
Why?
|
Femoral Vein | 1 | 2024 | 153 | 0.220 |
Why?
|
Multivariate Analysis | 14 | 2022 | 12043 | 0.220 |
Why?
|
Glucose | 1 | 2015 | 4345 | 0.220 |
Why?
|
Registries | 8 | 2024 | 8209 | 0.210 |
Why?
|
Reoperation | 6 | 2024 | 4300 | 0.210 |
Why?
|
Nanoparticles | 1 | 2014 | 1957 | 0.210 |
Why?
|
Cardiology | 4 | 2020 | 1656 | 0.210 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2022 | 62 | 0.200 |
Why?
|
Prospective Studies | 22 | 2024 | 54364 | 0.200 |
Why?
|
Aortic Valve | 4 | 2020 | 1955 | 0.200 |
Why?
|
Prosthesis Failure | 2 | 2020 | 1204 | 0.200 |
Why?
|
Stroke | 2 | 2023 | 9715 | 0.200 |
Why?
|
Anesthesia, Local | 1 | 2024 | 277 | 0.190 |
Why?
|
Apnea | 1 | 2023 | 195 | 0.190 |
Why?
|
Body Temperature | 2 | 2015 | 780 | 0.190 |
Why?
|
Glycogen Storage Disease Type IIb | 1 | 2021 | 18 | 0.190 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2006 | 709 | 0.190 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2024 | 285 | 0.190 |
Why?
|
Pre-Excitation Syndromes | 1 | 2021 | 27 | 0.190 |
Why?
|
Cardiac Electrophysiology | 2 | 2024 | 59 | 0.180 |
Why?
|
Metoprolol | 2 | 2019 | 90 | 0.180 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2004 | 1517 | 0.180 |
Why?
|
Cardiography, Impedance | 1 | 2020 | 40 | 0.180 |
Why?
|
Follow-Up Studies | 19 | 2021 | 39062 | 0.180 |
Why?
|
Odds Ratio | 10 | 2017 | 9644 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 8 | 2018 | 6473 | 0.170 |
Why?
|
Secondary Prevention | 3 | 2017 | 1470 | 0.170 |
Why?
|
Systole | 2 | 2019 | 935 | 0.170 |
Why?
|
Pennsylvania | 4 | 2009 | 612 | 0.160 |
Why?
|
Survival Rate | 7 | 2024 | 12719 | 0.160 |
Why?
|
Electrophysiology | 2 | 2015 | 1262 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 4 | 2023 | 20556 | 0.160 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4172 | 0.160 |
Why?
|
Aortic Valve Stenosis | 3 | 2020 | 2003 | 0.160 |
Why?
|
Incidence | 11 | 2021 | 21339 | 0.150 |
Why?
|
Abnormalities, Multiple | 2 | 2019 | 1422 | 0.150 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2373 | 0.150 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2019 | 477 | 0.150 |
Why?
|
Electroencephalography | 3 | 2011 | 6240 | 0.150 |
Why?
|
Cohort Studies | 12 | 2018 | 41464 | 0.150 |
Why?
|
Graft Rejection | 1 | 2011 | 4438 | 0.150 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 426 | 0.150 |
Why?
|
Disease Management | 3 | 2020 | 2506 | 0.150 |
Why?
|
Long QT Syndrome | 2 | 2013 | 466 | 0.150 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 1034 | 0.140 |
Why?
|
Primary Prevention | 2 | 2017 | 1185 | 0.140 |
Why?
|
Sus scrofa | 1 | 2018 | 428 | 0.140 |
Why?
|
Clinical Competence | 4 | 2024 | 4790 | 0.140 |
Why?
|
Thermal Conductivity | 1 | 2016 | 16 | 0.140 |
Why?
|
Feasibility Studies | 3 | 2024 | 5239 | 0.130 |
Why?
|
Doxorubicin | 1 | 2023 | 2224 | 0.130 |
Why?
|
Biophysical Phenomena | 1 | 2017 | 319 | 0.130 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2016 | 51 | 0.130 |
Why?
|
Prosthesis Fitting | 1 | 2016 | 75 | 0.130 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2016 | 38 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 323 | 0.130 |
Why?
|
Heart Defects, Congenital | 3 | 2019 | 4671 | 0.130 |
Why?
|
United States | 18 | 2024 | 72292 | 0.130 |
Why?
|
Steam | 1 | 2015 | 29 | 0.130 |
Why?
|
Logistic Models | 8 | 2017 | 13248 | 0.130 |
Why?
|
Genetics, Population | 2 | 2018 | 935 | 0.130 |
Why?
|
Diagnosis, Differential | 6 | 2020 | 12966 | 0.120 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2019 | 352 | 0.120 |
Why?
|
Necrosis | 1 | 2019 | 1610 | 0.120 |
Why?
|
Sleep Apnea, Central | 1 | 2016 | 88 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2019 | 576 | 0.120 |
Why?
|
Vectorcardiography | 1 | 2014 | 48 | 0.120 |
Why?
|
Fluoroscopy | 2 | 2024 | 945 | 0.120 |
Why?
|
Polymorphism, Genetic | 3 | 2018 | 4242 | 0.120 |
Why?
|
Loligo | 1 | 2014 | 1 | 0.120 |
Why?
|
Desmosomes | 1 | 2014 | 72 | 0.120 |
Why?
|
Electroshock | 1 | 2014 | 120 | 0.120 |
Why?
|
Geological Phenomena | 1 | 2014 | 11 | 0.120 |
Why?
|
Water Movements | 1 | 2014 | 17 | 0.120 |
Why?
|
Osmolar Concentration | 1 | 2015 | 659 | 0.120 |
Why?
|
Hemorrhage | 2 | 2023 | 3418 | 0.120 |
Why?
|
Friction | 1 | 2013 | 59 | 0.110 |
Why?
|
Prevalence | 7 | 2022 | 15702 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 3117 | 0.110 |
Why?
|
Data Interpretation, Statistical | 1 | 2023 | 2689 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3683 | 0.110 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 148 | 0.110 |
Why?
|
Chi-Square Distribution | 4 | 2015 | 3410 | 0.110 |
Why?
|
Echocardiography, Transesophageal | 3 | 2023 | 1085 | 0.110 |
Why?
|
Retreatment | 1 | 2015 | 596 | 0.110 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 3085 | 0.110 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2012 | 69 | 0.100 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2015 | 261 | 0.100 |
Why?
|
Depression | 2 | 2003 | 8132 | 0.100 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2013 | 122 | 0.100 |
Why?
|
Heparin | 1 | 2020 | 1632 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2020 | 1028 | 0.100 |
Why?
|
Transposition of Great Vessels | 2 | 2013 | 580 | 0.100 |
Why?
|
Biological Evolution | 1 | 2018 | 1070 | 0.100 |
Why?
|
Case-Control Studies | 8 | 2012 | 22153 | 0.100 |
Why?
|
Societies, Medical | 2 | 2020 | 3901 | 0.100 |
Why?
|
Insulin Resistance | 1 | 2006 | 3954 | 0.100 |
Why?
|
Phlebography | 1 | 2013 | 326 | 0.100 |
Why?
|
Mediastinal Diseases | 1 | 2012 | 91 | 0.100 |
Why?
|
Anticoagulants | 2 | 2024 | 4785 | 0.090 |
Why?
|
Preoperative Care | 2 | 2018 | 2242 | 0.090 |
Why?
|
Insulin | 1 | 2006 | 6593 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 3 | 2014 | 36401 | 0.090 |
Why?
|
Antidepressive Agents | 1 | 2003 | 2896 | 0.090 |
Why?
|
Comorbidity | 6 | 2017 | 10507 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8516 | 0.090 |
Why?
|
Models, Cardiovascular | 1 | 2016 | 981 | 0.090 |
Why?
|
Models, Animal | 1 | 2017 | 2108 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2007 | 10203 | 0.090 |
Why?
|
Surface Properties | 1 | 2013 | 1162 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4408 | 0.090 |
Why?
|
Lymphatic Diseases | 1 | 2012 | 320 | 0.090 |
Why?
|
Death, Sudden | 1 | 2012 | 301 | 0.090 |
Why?
|
Proportional Hazards Models | 6 | 2019 | 12448 | 0.090 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2013 | 246 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 825 | 0.090 |
Why?
|
Brugada Syndrome | 1 | 2011 | 91 | 0.090 |
Why?
|
Sensitivity and Specificity | 4 | 2014 | 14649 | 0.090 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2015 | 851 | 0.090 |
Why?
|
Motion | 1 | 2013 | 779 | 0.090 |
Why?
|
Spermatozoa | 1 | 2014 | 629 | 0.080 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2008 | 0.080 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2023 | 1877 | 0.080 |
Why?
|
Genetic Variation | 3 | 2018 | 6561 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 1 | 2019 | 1400 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2017 | 1553 | 0.080 |
Why?
|
Fontan Procedure | 1 | 2016 | 796 | 0.080 |
Why?
|
Medical Records | 1 | 2015 | 1408 | 0.080 |
Why?
|
Heart Valve Prosthesis | 1 | 2018 | 1462 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2016 | 1048 | 0.080 |
Why?
|
Latin America | 2 | 2020 | 407 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2022 | 2650 | 0.080 |
Why?
|
Asia | 2 | 2020 | 616 | 0.080 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2011 | 489 | 0.080 |
Why?
|
False Negative Reactions | 1 | 2009 | 573 | 0.080 |
Why?
|
Exanthema | 1 | 2013 | 503 | 0.080 |
Why?
|
Smoking | 2 | 2002 | 9054 | 0.080 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2013 | 628 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2020 | 3310 | 0.070 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2003 | 1723 | 0.070 |
Why?
|
Hemodynamics | 1 | 2017 | 4160 | 0.070 |
Why?
|
Young Adult | 11 | 2021 | 59191 | 0.070 |
Why?
|
Atlantic Ocean | 2 | 2018 | 24 | 0.070 |
Why?
|
Algorithms | 2 | 2006 | 14024 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2014 | 6223 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2016 | 18220 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1185 | 0.070 |
Why?
|
Muscle Proteins | 1 | 2011 | 1152 | 0.060 |
Why?
|
Aged, 80 and over | 12 | 2024 | 58919 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2013 | 1120 | 0.060 |
Why?
|
Sleep | 2 | 2023 | 4764 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2006 | 6305 | 0.060 |
Why?
|
Prognosis | 5 | 2019 | 29601 | 0.060 |
Why?
|
Morbidity | 2 | 2020 | 1750 | 0.060 |
Why?
|
Antihypertensive Agents | 2 | 2004 | 2018 | 0.060 |
Why?
|
Phenotype | 3 | 2018 | 16572 | 0.060 |
Why?
|
Lisinopril | 1 | 2004 | 61 | 0.060 |
Why?
|
Disease Progression | 2 | 2019 | 13495 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1496 | 0.060 |
Why?
|
Tetrahydroisoquinolines | 1 | 2004 | 81 | 0.060 |
Why?
|
Databases, Factual | 4 | 2024 | 7963 | 0.060 |
Why?
|
Multicenter Studies as Topic | 2 | 2016 | 1700 | 0.060 |
Why?
|
Protein Kinases | 1 | 2011 | 1606 | 0.060 |
Why?
|
Sulfonylurea Compounds | 1 | 2006 | 219 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1091 | 0.060 |
Why?
|
Postoperative Care | 1 | 2010 | 1467 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8652 | 0.060 |
Why?
|
Heart Aneurysm | 1 | 2024 | 114 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2009 | 2925 | 0.060 |
Why?
|
Microsatellite Repeats | 2 | 2018 | 783 | 0.060 |
Why?
|
Genotype | 4 | 2021 | 12977 | 0.060 |
Why?
|
Biopsy | 2 | 2015 | 6763 | 0.050 |
Why?
|
Accidental Falls | 1 | 2011 | 1067 | 0.050 |
Why?
|
Hospitalization | 4 | 2024 | 10708 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2006 | 460 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Benzazepines | 1 | 2004 | 310 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Inpatients | 1 | 2014 | 2545 | 0.050 |
Why?
|
Learning Curve | 1 | 2024 | 230 | 0.050 |
Why?
|
Hospital Mortality | 3 | 2020 | 5292 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6483 | 0.050 |
Why?
|
Sex Factors | 3 | 2024 | 10549 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3426 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2013 | 4470 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2003 | 1141 | 0.050 |
Why?
|
Fellowships and Scholarships | 2 | 2024 | 1116 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3442 | 0.050 |
Why?
|
Pneumonectomy | 1 | 2008 | 1119 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 12143 | 0.050 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2003 | 324 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 694 | 0.050 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 53 | 0.050 |
Why?
|
DNA, Mitochondrial | 2 | 2018 | 865 | 0.050 |
Why?
|
Chloroquine | 1 | 2022 | 275 | 0.040 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 577 | 0.040 |
Why?
|
Polysomnography | 2 | 2017 | 1852 | 0.040 |
Why?
|
Models, Biological | 1 | 2016 | 9461 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3575 | 0.040 |
Why?
|
Mortality | 2 | 2022 | 2899 | 0.040 |
Why?
|
Proteins | 1 | 2014 | 6030 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2020 | 92 | 0.040 |
Why?
|
Lung | 1 | 2017 | 9999 | 0.040 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2575 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 317 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2011 | 3735 | 0.040 |
Why?
|
Angola | 1 | 2018 | 18 | 0.040 |
Why?
|
Sample Size | 1 | 2001 | 838 | 0.040 |
Why?
|
Tomography | 1 | 2020 | 411 | 0.040 |
Why?
|
Seizures | 1 | 2011 | 2964 | 0.040 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2017 | 24 | 0.040 |
Why?
|
Metformin | 1 | 2006 | 906 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2004 | 1040 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3919 | 0.040 |
Why?
|
Adolescent | 8 | 2021 | 88247 | 0.040 |
Why?
|
Antithrombins | 1 | 2020 | 292 | 0.040 |
Why?
|
India | 2 | 2015 | 2286 | 0.040 |
Why?
|
Decision Trees | 1 | 2018 | 504 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2005 | 1489 | 0.030 |
Why?
|
Sex Distribution | 1 | 2002 | 2278 | 0.030 |
Why?
|
Regression Analysis | 1 | 2006 | 6339 | 0.030 |
Why?
|
Probability | 1 | 2002 | 2475 | 0.030 |
Why?
|
Tricuspid Valve | 1 | 2019 | 409 | 0.030 |
Why?
|
Recovery of Function | 1 | 2006 | 2977 | 0.030 |
Why?
|
Age Distribution | 1 | 2002 | 2872 | 0.030 |
Why?
|
Germany | 1 | 2018 | 872 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 250 | 0.030 |
Why?
|
DNA | 2 | 2021 | 7196 | 0.030 |
Why?
|
Italy | 1 | 2017 | 842 | 0.030 |
Why?
|
Pedigree | 2 | 2014 | 4539 | 0.030 |
Why?
|
Credentialing | 1 | 2015 | 115 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2019 | 675 | 0.030 |
Why?
|
Health Planning Guidelines | 1 | 2015 | 151 | 0.030 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2016 | 140 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2110 | 0.030 |
Why?
|
Drug Resistance | 2 | 2012 | 1594 | 0.030 |
Why?
|
Reference Values | 1 | 2002 | 4919 | 0.030 |
Why?
|
Hypertension | 2 | 2004 | 8532 | 0.030 |
Why?
|
Phylogeography | 1 | 2014 | 72 | 0.030 |
Why?
|
Fragile X Syndrome | 1 | 1995 | 116 | 0.030 |
Why?
|
Gene Flow | 1 | 2014 | 78 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 527 | 0.030 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 1995 | 430 | 0.030 |
Why?
|
Dyneins | 1 | 2014 | 124 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2014 | 1493 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3415 | 0.030 |
Why?
|
Species Specificity | 2 | 2014 | 2410 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2002 | 2188 | 0.030 |
Why?
|
Independent Living | 1 | 2017 | 577 | 0.030 |
Why?
|
Solvents | 1 | 2014 | 294 | 0.030 |
Why?
|
Education | 1 | 2015 | 534 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4110 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3688 | 0.030 |
Why?
|
South Africa | 1 | 2018 | 1843 | 0.030 |
Why?
|
Artifacts | 2 | 2014 | 1910 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2016 | 15498 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2019 | 20077 | 0.020 |
Why?
|
Haplotypes | 1 | 2018 | 2713 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 7873 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2011 | 6403 | 0.020 |
Why?
|
Situs Inversus | 1 | 2011 | 63 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2016 | 1734 | 0.020 |
Why?
|
North America | 1 | 2015 | 1273 | 0.020 |
Why?
|
Risk | 1 | 2003 | 9603 | 0.020 |
Why?
|
Stents | 1 | 2003 | 3177 | 0.020 |
Why?
|
Contrast Media | 1 | 2024 | 5305 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2003 | 2746 | 0.020 |
Why?
|
Mitral Valve | 1 | 2019 | 1464 | 0.020 |
Why?
|
Injections | 1 | 2014 | 832 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18381 | 0.020 |
Why?
|
Cardiac Imaging Techniques | 1 | 2013 | 266 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2805 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2003 | 4937 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1431 | 0.020 |
Why?
|
Penetrance | 1 | 2011 | 382 | 0.020 |
Why?
|
Exercise Test | 1 | 2017 | 2127 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2015 | 912 | 0.020 |
Why?
|
Child | 4 | 2021 | 80089 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15829 | 0.020 |
Why?
|
Hospitals | 1 | 2002 | 3879 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1776 | 0.020 |
Why?
|
Ligation | 1 | 2008 | 446 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2601 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3303 | 0.020 |
Why?
|
New York | 1 | 2010 | 875 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2114 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2120 | 0.020 |
Why?
|
Rats | 1 | 2023 | 23716 | 0.020 |
Why?
|
Family Health | 1 | 2011 | 1253 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1971 | 0.020 |
Why?
|
Point Mutation | 1 | 2011 | 1595 | 0.020 |
Why?
|
Fatigue | 1 | 2013 | 1550 | 0.020 |
Why?
|
Heterozygote | 1 | 2012 | 2780 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10072 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2007 | 245 | 0.020 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1002 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10754 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9277 | 0.020 |
Why?
|
Syndrome | 1 | 2011 | 3268 | 0.020 |
Why?
|
Patients | 1 | 2011 | 906 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6807 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3727 | 0.020 |
Why?
|
Genetic Testing | 1 | 2017 | 3533 | 0.010 |
Why?
|
Proteome | 1 | 2014 | 1857 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7403 | 0.010 |
Why?
|
Sensory Thresholds | 1 | 2005 | 377 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2011 | 13442 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12333 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2011 | 17630 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2014 | 12759 | 0.010 |
Why?
|
Metals | 1 | 2007 | 719 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10759 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3739 | 0.010 |
Why?
|
Postoperative Period | 1 | 2006 | 1812 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2011 | 1419 | 0.010 |
Why?
|
Qualitative Research | 1 | 2011 | 3017 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3527 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 817 | 0.010 |
Why?
|
Safety | 1 | 2005 | 1149 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6418 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26183 | 0.010 |
Why?
|
Coronary Restenosis | 1 | 2002 | 396 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4472 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 12942 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2011 | 3239 | 0.010 |
Why?
|
Treatment Failure | 1 | 2003 | 2635 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 4010 | 0.010 |
Why?
|
Practice Guidelines as Topic | 2 | 2005 | 7390 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30015 | 0.010 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 1995 | 115 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15908 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 26065 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4058 | 0.010 |
Why?
|
Xenopus Proteins | 1 | 1995 | 434 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1995 | 1162 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1995 | 1989 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1995 | 2261 | 0.010 |
Why?
|
Xenopus laevis | 1 | 1995 | 963 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1995 | 2747 | 0.010 |
Why?
|
Research Design | 1 | 2006 | 6174 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4172 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4611 | 0.000 |
Why?
|
RNA-Binding Proteins | 1 | 1995 | 1890 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12420 | 0.000 |
Why?
|
Gene Expression | 1 | 1995 | 7569 | 0.000 |
Why?
|